Bullish option flow detected in Novavax (NVAX) with 15,177 calls trading, 3x expected, and implied vol increasing almost 8 points to 71.12%. 1/23 weekly 9 calls and 1/23 weekly 8.5 calls are the most active options, with total volume in those strikes near 7,000 contracts. The Put/Call Ratio is 0.07. Earnings are expected on February 26th.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVAX:
- Novavax: Execution Risks, Long-Dated Cash Flows, and COVID Market Headwinds Undermine Profitability Outlook
- Novavax: Pfizer Partnership Validates Matrix‑M Platform and Supports Upside in Capital‑Light Growth Strategy
- Novavax price target raised to $7 from $6 at BofA
- Novavax: Expanding Matrix-M Licensing Partnerships Drive Upside Potential and Support Buy Rating
- Novavax enters license agreement with Pfizer for use of Matrix-M
